Dark Forest Capital Management LP Atara Biotherapeutics, Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.85 - $5.18 $12,021 - $21,849	-4,218 Reduced 99.65%	15 $0
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $9,644 - $29,542	3,384 Added 398.59%	4,233 $16,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $3,981 - $8,354	849 New	849 $7,000
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $2,565 - $5,134	-304 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $3,851 - $5,211	-262 Reduced 46.29%	304 $5,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $83,414 - $124,530	-6,957 Reduced 92.48%	566 $10,000
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $96,971 - $124,731	7,523 New	7,523 $117,000

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $720M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.